Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C (P05063)
Clinical trial NCT00689390 · TERMINATED
Trial details
- NCT number
- NCT00689390
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-20
- Primary completion
- 2014-10-13
- Enrollment
- 1954
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.